Millennium
Biotechnologies Inc., wholly-owned subsidiary of Millennium Biotechnologies
Group, Inc. (OTC Bulletin Board: MBTG), announced that Surgex(TM)
(surgexsports) has been tested and certified into the Banned
Substance Control Group's (BSCG) certification program. This is the only
certification program in the US that uses a World Anti Doping Agency
accredited laboratory to detect for dangerous banned substances in
nutritional supplements. Each batch of Millennium's line of Surgex(TM)
products are now tested and certified not to contain substances such as
hormones, steroids, stimulants, diuretics, etc that are banned for
Professional, Collegiate and Olympic sports. The BSCG certification in
addition to the Surgex'(TM) clinical trials should provide the product a
competitive advantage upon commercialization into the billion dollar sports
nutritional supplement marketplace.
"The athlete can now be assured that our Surgex(TM) line of products
can be safely consumed as each batch is tested for a list of substances
that are banned by organizations such as the International Olympic
Committee (IOC), the World Anti-Doping Agency (WADA), the United States
Anti-Doping Agency (USADA), the National Collegiate Athletic Association
(NCAA), the National Football League (NFL), and many other professional and
amateur sports leagues." states Carl Germano, RD, CNS, CDN, clinical
nutritionist and VP of Research & product Development for Millennium
Biotechnologies.
With over 5 years in the medical market as a nutritional adjunct to
medical care for immuno-compromised conditions and several successful
studies including 2 double blind, placebo controlled trials in Division 1
athletes, the Surgex(TM) line of products is breaking new ground for
credibility and professionalism in the sports nutrition sector.
The final set of results from Millennium's sponsored Division 1
Football trial at Rutgers University have shown that Surgex(TM) had a
significant effect on recovery markers including testosterone:cortisol
ratios compared to a market leading sports beverage on the market. "Along
with our previous statistically significant improvements in body
composition and strength parameters, the recovery marker data continues to
validate Surgex(TM) as an important nutritional adjunct for the athlete"
states Mr. Germano. "As we have seen in the medical market, Surgex is now
able to offer the athlete a product that will assist in recovery in efforts
to improve performance. In addition, our participation in the BSCG program
continues to set us apart from the competition."
The continued usage and acceptability of Surgex(TM) by Professional,
Olympic, and Collegiate athletes is providing the valuable market
information which will allow Millennium to develop the best strategy to
commercialize Surgex(TM), expected in Q3 of 2008.
About Surgex(TM):
Surgex(TM) (surgexsports) was created from Millennium's
extensive experience providing advanced nutritional formulas to some of the
most prestigious medical institutions throughout the United States The
proprietary Surgex(TM) formula intends to meet the growing demand of elite
level Professional, Olympic and amateur athletes and their coaches looking
for nutritional support in a marketplace dominated by products with no
clinical proof of benefit, unsubstantiated claims, excess protein,
stimulants, and banned substances.
In double blind placebo controlled trials at the Rutgers University
Human Performance Lab Surgex(TM) significantly outperformed leading
competitive products by assisting in reducing the damaging effects of
exercise by improving peak power outputs, lowering oxidative
stress/inflammatory markers, reducing fatigue (poor energy recovery) and
the breakdown of muscle (post exercise wasting), as well as the lessening
of free radical production (oxidative stress). The formula meets NCAA
guidelines for use by collegiate athletes and is certified by The Banned
Substances Control Group (BSCG) to contain no banned substances.
About Millennium:
Millennium's three proprietary, marketed products, which form the
Company's Resurgex(R) Continuum of Care, include Resurgex Select(R),
Resurgex(R), and Resurgex Plus(R). Resurgex Select(R) is a whole
foods-based, calorically dense, high-protein nutritional formula developed
for cancer patients undergoing chemotherapy or radiation treatments.
Resurgex(R) and Resurgex Plus(R) are specialized, anabolic nutritional
supplements rich in antioxidants that provide nutritional support
post-treatment. Millennium is also recently developed a Surgex(TM) sports
nutrition formula, clinically proven to address the nutritional concerns of
the Professional, Olympic and amateur elite athletes. These athletes often
experience similar symptoms post- workout to those battling
immuno-compromised conditions, such as fatigue, loss of lean muscle,
oxidative stress, and reduced immune function.
Statements in this news release regarding future financial and
operating results, future growth in R&D programs, potential applications of
the Company's technology, opportunities for the Company, and any other
statements about the future expectations, beliefs, goals, plans, or
prospects expressed constitute forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Any
statements that are not statements of historical fact (including statements
containing the words "will," "believes," "plans," "anticipates," "expects,"
"estimates," and similar expressions) should also be considered to be
forward-looking statements. There are a number of important factors that
could cause actual results or events to differ materially from those
indicated by such forward- looking statements including: limited operating
history, need for future capital, risks inherent in the development and
commercialization of potential products, protection of the Company's
intellectual property, and economic conditions generally. Additional
information on potential factors that could affect results and other risks
and uncertainties are detailed from time to time in the Company's periodic
reports, including Forms 10-KSB, 10-QSB, 8-K, and other forms filed with
the Securities and Exchange Commission ("SEC"). These statements have not
been evaluated by the Food and Drug Administration. Resurgex(R), Resurgex
Plus(R), Resurgex Select(R) and Surgex(TM) are not intended to diagnose,
treat, cure, or prevent and disease.
Millennium Biotechnologies Inc.
milbiotech